On the Frontlines of IgA Nephropathy
Stay up to date on the latest advancements in the management of the most prevalent primary glomerulonephritis worldwide with our exclusive podcast series, On the Frontlines of IgA Nephropathy. Tune in to hear from leading nephropathy experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this leading cause of kidney failure.
What the Latest IgAN Clinical Trials Mean for Patient Care
On the Frontlines of IgA NephropathyWhat the Latest IgAN Clinical Trials Mean for Patient Care
Steve Jackson, PharmD
Andrew S. Bomback, MD, MPH
Gates B. Colbert, MD
Anjay Rastogi, MD, PhD
Targeting BAFF and APRIL in IgA Nephropathy
On the Frontlines of IgA NephropathyTargeting BAFF and APRIL in IgA Nephropathy
Gates B. Colbert, MD
Edgar V. Lerma, MD, FACP, FASN, FPSN (Hon)
Early Combination Therapy in IgA Nephropathy
On the Frontlines of IgA NephropathyEarly Combination Therapy in IgA Nephropathy
Gates B. Colbert, MD
Sayna Norouzi, MD
Reading the Warning Signs: Risk Stratification in IgAN
On the Frontlines of IgA NephropathyReading the Warning Signs: Risk Stratification in IgAN
Gates B. Colbert, MD
Dustin Le, MD, MHS
Deciphering IgA Nephropathy: Insights into the Diagnostic Process
On the Frontlines of IgA NephropathyDeciphering IgA Nephropathy: Insights into the Diagnostic Process
Gates B. Colbert, MD
The Diagnostic Journey of IgA Nephropathy: Identifying Key Obstacles
On the Frontlines of IgA NephropathyThe Diagnostic Journey of IgA Nephropathy: Identifying Key Obstacles
Gates B. Colbert, MD
Unlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
On the Frontlines of IgA NephropathyUnlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
Suneel Udani, MD
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
On the Frontlines of IgA NephropathyDiagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
Gates B. Colbert, MD
Agnes B. Fogo, MD
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
Gates B. Colbert, MD
Edward Filippone, MD
Reducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
On the Frontlines of IgA NephropathyReducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
Jonathan Barratt, MD, PhD
Innovations in IgAN Care: Examining the Evolving Treatment Landscape
On the Frontlines of IgA NephropathyInnovations in IgAN Care: Examining the Evolving Treatment Landscape
Jonathan Barratt, MD, PhD
The Future of IgA Nephropathy: Why Biomarkers Matter
On the Frontlines of IgA NephropathyThe Future of IgA Nephropathy: Why Biomarkers Matter
Jonathan Barratt, MD, PhD
Identifying Unmet Needs in the Management of Glomerular Diseases
Clinician's RoundtableIdentifying Unmet Needs in the Management of Glomerular Diseases
Frank Cortazar, MD
Challenging Common Misconceptions About IgAN
Clinician's RoundtableChallenging Common Misconceptions About IgAN
Frank Cortazar, MD
- advertisement
